Edition:
United Kingdom

Cardiovascular Systems Inc (CSII.OQ)

CSII.OQ on NASDAQ Stock Exchange Global Select Market

22.66USD
24 Apr 2018
Change (% chg)

$0.16 (+0.71%)
Prev Close
$22.50
Open
$22.54
Day's High
$22.66
Day's Low
$22.54
Volume
1,619
Avg. Vol
95,030
52-wk High
$33.10
52-wk Low
$20.59

Latest Key Developments (Source: Significant Developments)

Cardiovascular Systems Inc reports Q1 loss per share $0.06
Wednesday, 25 Oct 2017 

Oct 25 (Reuters) - Cardiovascular Systems Inc ::Cardiovascular Systems Inc reports fiscal 2018 first-quarter financial results.Q1 loss per share $0.06.Q1 revenue $49.7 million versus I/B/E/S view $51 million.Q1 earnings per share view $-0.07 -- Thomson Reuters I/B/E/S.Sees Q2 2018 loss per share $0.03 to $0.06.Sees FY 2018 revenue $226 million to $233 million.Sees Q2 2018 revenue $52.5 million to $54 million.Q2 earnings per share view $-0.01, revenue view $55.1 million -- Thomson Reuters I/B/E/S.FY2018 revenue view $227.6 million -- Thomson Reuters I/B/E/S.  Full Article

Cardiovascular Systems names Scott Ward as CEO
Tuesday, 16 Aug 2016 

Cardiovascular Systems Inc : Cardiovascular Systems names Scott Ward as CEO . Cardiovascular Systems Inc says Scott R. Ward, company's new chairman and chief executive officer, effective immediately .Scott Ward has been serving as chairman since November 2014 and interim president and CEO since November 2015.  Full Article

Cardiovascular Systems reports Q4 loss per share $0.15
Wednesday, 3 Aug 2016 

Cardiovascular Systems Inc : Q4 revenue $48.5 million versus I/B/E/S view $46 million . Q4 earnings per share view $-0.20 -- Thomson Reuters I/B/E/S . Quarter financial results . Q4 loss per share $0.15 . Sees q1 revenue in a range of $48.0 million to $49.5 million . Sees q1 loss per common share ranging from $0.18 to $0.21 .Q1 earnings per share view $-0.22, revenue view $45.9 million -- Thomson Reuters I/B/E/S.  Full Article

Cardiovascular Systems announces settlement agreement to resolve investigation by DOJ, qui tam complaint filed by Travis Thams
Tuesday, 28 Jun 2016 

Cardiovascular Systems Inc : Settlement agreement with United States of America, to resolve investigation by DOJ, qui tam complaint filed by Travis Thams . Under the settlement agreement, the company will pay $8 million - SEC filing .Will also be required to pay Thams' reasonable expenses, costs and attorney’s fees, which amount has not yet been determined.  Full Article

BRIEF-Cardiovascular Systems Says OrbusNeich 1.0mm Sapphire II PRO Coronary Balloon Granted FDA Clearance

* CARDIOVASCULAR SYSTEMS, INC. AND ORBUSNEICH ANNOUNCE FDA CLEARANCE OF THE FIRST AND ONLY 1.0MM CORONARY BALLOON IN THE U.S.